In patients with heart failure and reduced left ventricular ejection fraction (LVEF< 35%), there
is an increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias (VA), with …

Properly programming pacemakers and defibrillators siginificantly affects their function and
the patient's health. Proper programming can add years to device longevity, prevent …

Methods: 220episodes from 38 patients with single chamber ICDs that RV overdrive pacing
could not terminate or change the tachycardia cycle length (TCL) were retrospectively …

We read with great interest the Featured Arrhythmia by Metzl et al 1 in the February 2011
issue of Heart Rhythm. We agree with the authors that the findings clearly point to the …

El desfibrilador automático implantable ha demostrado su eficacia y seguridad para tratar
arritmias ventriculares. Dispone de dos opciones terapéuticas fundamentales: la …

Der implantierbare Cardioverter-Defibrillator (ICD) ist eine effektiv Methode zur
Verhinderung des plötzlichen Herztodes 1-4 und sowohl in der Sekundär-als auch in der …

Implantierbare Cardioverter/Defibrillatoren (ICD) verhindern wirksam den plötzlichen
Herztod. Sie sind aber mit dem Risiko inadäquater Schockabgaben, meist verursacht durch …

Previous randomized controlled trials have shown that the implantable cardioverter–
defibrillator (ICD) provides a significant mortality reduction in patients at high risk of sudden …

Implantable cardioverter defibrillators (ICDs) have become very useful for patients with a
high risk of sudden cardiac death, based on the results of several clinical trials. Although …

Implantable cardioverter-defibrillators (ICDs) reduce mortality among high-risk patients with
indication for primary or secondary prevention of sudden cardiac death. 1–3 Defibrillator …